Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats

Area of Science:

• Nephrology
• Cardiovascular Physiology
• Metabolic Syndrome

Background:

• Insulin resistance and hypertension are significant health concerns.
• Fructose-rich diets are linked to metabolic dysfunction and cardiovascular issues.
• Dietary sodium intake modulates blood pressure and kidney function.

Purpose of the Study:

• To investigate the role of endothelial NO synthase (eNOS) in fructose-fed insulin-resistant rats (FFR) under varying sodium conditions.
• To determine the effect of pioglitazone on hypertension and eNOS expression in FFR.

Main Methods:

• Male Sprague-Dawley rats were fed control or high-fructose diets with low or high sodium content for two weeks.
• Systolic blood pressure and renal medullary eNOS protein expression were measured.
• Half of the fructose-fed rats received pioglitazone, an insulin-sensitizing agent.

Main Results:

• High-sodium fructose-fed rats exhibited significantly higher systolic blood pressure compared to controls or low-sodium fructose-fed rats, indicating salt-dependent hypertension.
• Renal medullary eNOS protein expression was significantly lower in fructose-fed rats on a high-sodium diet.
• Pioglitazone treatment normalized blood pressure and prevented the reduction in medullary eNOS expression in high-sodium fructose-fed rats.

Conclusions:

• A decrease in renal medullary NO production by eNOS may contribute to salt-sensitive hypertension in fructose-fed rats.
• Pioglitazone effectively mitigates hypertension and preserves eNOS expression in this model.
• These findings highlight the interplay between diet, insulin resistance, sodium, and renal NO pathways in hypertension.